Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
Journal Articles
Cost Sharing for Preferred Branded Drugs in Medicare Part D
Featured Experts: Erin Trish
In The News View All
Medscape
Medicare coverage of obesity drugs could presure other insurers to follow suit, Ward says
Featured Experts: Alison Sexton Ward
Oprah Daily
Qato discusses disparities in GLP-1 coverage
Featured Experts: Dima M. Qato
STAT
Medicare Should Cover Wegovy — but Not Negotiate Its Price
Featured Experts: Joseph Grogan
Bloomberg Law
The first round of Medicare drug negotiations lacked true transparency, Lakdawalla explains
Featured Experts: Darius Lakdawalla
Yahoo Finance
Medicare coverage of GLP-1s could make doctors more accepting of the drugs, Goldman says
Featured Experts: Dana Goldman
Featured Perspective
Medicare Should Cover Wegovy — but Not Negotiate Its Price
Subjecting Wegovy to price controls would crush innovation and discourage new entrants to this important new class of anti-obesity medications that could help millions of Americans.
Experts: Joseph Grogan
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
